Enjoy complimentary customisation on priority with our Enterprise License!
The global vertigo drugs market size is estimated to grow by USD 551.42 million at a CAGR of 5.58% between 2022 and 2027. A significant driver propelling the global market is the escalating demand for the drugs observed in developing nations. These include rapidly growing economies like India, China, Brazil, South Africa, Indonesia, Mexico, among others. These regions are experiencing a surge in healthcare expenditures alongside rapid economic growth, fostering a heightened demand for advanced medical treatments and pharmaceuticals. Moreover, the ongoing expansion of healthcare infrastructure across these emerging economies is playing a pivotal role in driving the demand for the treatments. Investments in hospitals, clinics, and pharmacies are enhancing healthcare accessibility and contributing to the availability of a diverse range of medications. Consequently, the burgeoning demand in emerging markets is anticipated to fuel market growth throughout the forecast period.
To learn more about this report, Request Free Sample
The market share growth by the peripheral vertigo segment will be significant during the forecast period. An issue with the portion of the inner ear that controls balance is the cause ofthis segment. These areas are called the vestibular labyrinth or semicircular canals. The vestibular nerve may potentially be a factor in the issue. This nerve links the inner ear to the brain stem. Approximately 80% of vertigo is peripheral.
Get a glance at the market contribution of various segments View a PDF Sample
The peripheral vertigo segment was valued at USD 1.07 billion in 2017. This condition may be caused by injury, certain medicines, such as aminoglycoside antibiotics, cisplatin, irritation and swelling of the inner ear, meniere disease, and others. Patients typically develop rapid, severe nausea, vomiting, and gait instability. Antihistamines, benzodiazepines, corticosteroids, antiemetics, and anticholinergics may be used in the treatment of this segment. Furthermore, various market players, such as Sensorion and Viatris provide drugs for this segment, which will boost the segment during the forecast period.
The offline segment held the largest share of the global market in 2022. The majority of customers prefer to buy through offline distribution channels because they offer product assurance, authenticity, and verification. Besides, offline retailers give customers convenience, personalization, and personal support. Moreover, companies and market players significantly invest in brick-and-mortar organized pharmaceutical retail stores to raise their regional and global shares in the market. companies are investing in brick-and-mortar stores to sell due to the increased footfall in offline stores. Due to the rise in the retail sector, it is expected to fuel offline segment growth during the forecast period.
For more insights about various regions' market share, View PDF Sample now!
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have explained the regional trends and drivers that will shape the market during the forecast period. North America involves nations like the US, Canada, and Mexico, and it addresses the development, manufacturing, and consumption, which is driving the development of the regional market.
Moreover, several prominent pharmaceutical companies that develop and manufacture medications for treatment are based in the region. Amneal Pharmaceuticals, Epic Pharma, and Viatris are a few of the market's companies. With large-scale investments in research and development (R&D), these companies introduce innovative drugs with enhanced efficacy and safety profiles. The region's availability of a wide range of vertigo medications is facilitated by the region's well-established pharmaceutical infrastructure and expertise, boosting the growth of the market during the forecast period.
Buy Now Full Report and Discover More
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies,
Altamira Therapeutics Ltd.: The company offers vertigo drugs such as ALTA-5206.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The growing prevalence of vertigo and associated health concerns is a prominent driver for the Market. Lifestyle factors such as obesity, respiratory problems, diabetes, and high cholesterol levels contribute to the incidence of vertigo among overweight and obese individuals. As the global population continues to grapple with chronic and acute diseases, the demand for vertigo medications, including those addressing atherosclerosis and cardiovascular issues, rises. Additionally, advancements in cardiac surgeries, heart transplantations, and other surgical procedures necessitate effective vertigo management pharmaceuticals to mitigate post-operative symptoms like chest pain and dizziness. Moreover, the adoption of statins for managing cholesterol levels underscores the need for vertigo drugs, further propelling market growth.
In parallel, a notable trend in the Market is the integration of innovative technologies to enhance patient care and treatment outcomes. The adoption of customer relationship management (CRM) systems enables pharmaceutical companies to streamline interactions with healthcare providers and optimize revenue generation. Furthermore, the increasing demand for web and mobile self-services allows patients to access information about vertigo medications conveniently, fostering real-time communication and instant assistance. Additionally, the integration of social media platforms facilitates engagement with end-users, providing valuable insights into user behavior and enhancing the overall customer experience. As the e-commerce sector continues to expand, the deployment of interactive chatbots and customer messaging software enables personalized interactions and supports the management of vertigo-related inquiries, catering to the diverse needs of first-time website visitors, existing users, and returning customers.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key trends, and challenges.
The burgeoning trend of integrating digital health solutions into the treatment is significantly propelling the growth of the global market. This integration represents a pivotal shift in patient care strategies, leveraging innovative digital platforms to enhance vertigo management. Digital health solutions, including telehealth platforms, are revolutionizing the way vertigo symptoms are tracked, monitored, and addressed. Through telehealth platforms, patients can access remote consultations and virtual visits with healthcare professionals, facilitating real-time guidance and monitoring of their condition.
The integration of digital health solutions offers a multitude of benefits for the treatment. By enabling real-time data collection and remote monitoring, these solutions facilitate timely interventions and adjustments to treatment regimens, ultimately leading to improved patient outcomes. Moreover, digital health solutions enhance patient engagement and empowerment, fostering a more proactive approach to vertigo management. As a result, the integration of digital health solutions is expected to drive significant advancements in vertigo treatment and contribute to the growth of the market in the forecast period.
The presence of generic drugs in the past few years has harmed the growth of the global market. Generic drugs are defined as inexpensive drugs that contain the same active ingredient (API) as branded drugs. These drugs are launched shortly after the brand loses its patent exclusivity. Following the loss of patent exclusivity, the generic competition for a product increases, leading to a decline in the sale of branded drugs as the generic competitor enters the market with the same product at lower prices.
Moreover, generic drugs also make the threat of new entrants in the market, which will damage the market position of the existing companies and market players. Once these generics are launched in developed countries, they reach developing countries within a short period. Such instances will impede the market growth during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Market Customer Landscape
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
The market is witnessing significant growth owing to the increasing prevalence of vertigo, often caused by viral or bacterial infections, inner ear inflammation, or disorders in the brain. With technological advancements and ongoing innovation, new treatments are emerging to address symptoms like spinning dizziness and difficulty in balancing. Pharmaceutical companies, both public and private, are investing in research and development, leading to new product launches and expansions. Additionally, mergers, acquisitions, and joint ventures are shaping the market landscape. As the geriatric population grows and healthcare expenditure rises, there is a heightened demand for vertigo treatments. Vertigo drugs like dimenhydrinate and meclizine are commonly prescribed, available in various forms from hospital pharmacies to online providers, catering to the needs of patients globally.
The vertigo treatment market is a dynamic sector influenced by various factors, including advancements in medical research, changes in healthcare policies, and the occurrence of health conditions like vertigo and dizziness. As public and private companies invest in research and development, the market for vertigo treatments evolves to meet the needs of patients experiencing these debilitating symptoms.
In recent times, the pandemic has posed unique challenges, with social distancing measures affecting patient visits to healthcare facilities. However, studies published in journals such as the Ear Nose and Throat Journal and the Journal of Neurology provide valuable insights into the incidence and prevalence of peripheral etiologies of vertigo, helping doctors better understand and manage these conditions. The impact of vertigo is particularly significant among specific demographics, including women, elderly people, and nursing home patients. Research published in outlets like the BioMed Central (BMC) Geriatric Journal sheds light on the prevalence of vertigo in these populations and underscores the importance of tailored treatment approaches.
Key contributors to vertigo include conditions such as Meniere's Disease, benign paroxysmal positional vertigo (BPPV), vestibular neuritis, and labyrinthitis, each requiring targeted interventions. Clinical trials, including phase 3 trials, play a crucial role in evaluating the efficacy and safety of potential treatments for these conditions. Treatment options range from medications such as water pills and antidepressants, available both over-the-counter and through drug stores and retail pharmacies, to physical therapy and surgical interventions in severe cases. Collaboration between healthcare professionals, researchers, and pharmaceutical companies is essential in advancing treatment options and improving patient outcomes.As research continues to uncover the underlying causes of vertigo and dizziness, including disorders in the brain or inner ear, efforts are made to enhance diagnostic accuracy and develop personalized treatment plans. Through initiatives led by organizations like the National Center for Biotechnology Information (NCBI) and the World Health Organization (WHO), the vertigo treatment market strives to address the diverse needs of patients across the globe, ensuring access to quality care for all.
Vertigo Drugs Market Scope |
|
Report Coverage |
Details |
Page number |
149 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.58% |
Market growth 2023-2027 |
USD 551.42 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
4.69 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
AdvaCare Pharma, Altamira Therapeutics Ltd., Amneal Pharmaceuticals Inc., Endo International Plc, Epic Pharma LLC, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Indicus Pharma, Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., Lupin Ltd., Novartis AG, Otonomy Inc., Pfizer Inc., Sensorion, Sound Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Suven Life Sciences Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. |
Market dynamics |
Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.